Is a complete AYTU research report available?

No complete published report is available for Aytu BioPharma, Inc. (AYTU) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Aytu BioPharma, Inc. (AYTU)

NASDAQ: AYTU · USD

$2.16

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first AYTU analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	23.2M
Revenue (ttm)	56.6M
Net income (ttm)	-34.1M
EPS (ttm)	-$3.71
Shares out	10.7M
Volume	10,404
Beta	0.25
Price target	$9.50	+339.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 56.6M
Net income (ttm): -34.1M
EPS (ttm): -$3.71
Market cap: 23.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All AYTU indicators

Market & fundamental data

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001385818
Company name	Aytu BioPharma, Inc.
Country	United States
Country code	US
Cusip	054754858
Employees	83
Employees Change	-16%
Employees Change Percent	-16.16
Enterprise value	$19.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	126.3
Industry PE Fwd	14.06
Isin	US0547548588
Last refreshed	2026-07-26
Market cap	$23.2M
Market cap category	Nano-Cap
Price	$2.16
Price currency	USD
Rev Per Employee	681,915.66x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	AYTU
Website	https://aytubio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-146.89%
EV Sales Forward	0.31x
EV/FCF	11.8x
EV/Sales	0.34x
FCF yield	7.09%
P/B ratio	0.66x
P/S ratio	0.41x
PS Forward	0.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.18%
EBITDA Margin	-2.22%
FCF margin	2.9%
Gross margin	64.78%
Gross Profit	$36.7M
Gross Profit Growth	-21.37%
Gross Profit Growth Q	-40.66%
Gross Profit Growth3 Y	-15.57%
Gross Profit Growth5 Y	5.95%
Net Income	$-34.1M
Net Income Growth Years	3%
Pretax Margin	-59.49%
Profit Margin	-60.17%
Profit Per Employee	$-410,301
ROA	-3.66
Roa5y	-4.8
ROCE	-7.86
ROE	-97.42
Roe5y	-57.18
ROIC	-36.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-69.38%
Cagr1y	-17.88%
Cagr3y	6.07%
Cagr5y	-51.68%
EPS Growth Years	3
Revenue Growth	-14.04x
Revenue Growth Q	-32.74x
Revenue Growth Years	1x
Revenue Growth3 Y	-18.39x
Revenue Growth5 Y	-0.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.48
Assets	$111.7M
Cash	$26.7M
Current Assets	$67.3M
Current Liabilities	$60M
Debt	$22.9M
Debt Equity	$0.65
Debt FCF	$13.95
Equity	$35.1M
Interest Coverage	-1.81
Liabilities	$76.5M
Long Term Assets	$44.4M
Long Term Liabilities	$16.6M
Net Cash	$3.8M
Net Cash By Market Cap	$16.29
Net Debt Equity	$-0.11
Net Debt FCF	$-2.3
Tangible Book Value	$-7.3M
Tangible Book Value Per Share	$-0.68
WACC	6.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.12
Inventory Turnover	2.15
Net Working Capital	$-6.9M
Quick ratio	0.85
Working Capital	$7.4M
Working Capital Turnover	$12.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.94%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-17.87%
200-day SMA	2.38
3Y total return	19.34%
50-day SMA	2.19
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.37%
All Time High	11,331,775.7
All Time High Change	-100%
All Time High Date	2015-04-24
All Time Low	0.95
All Time Low Change	127.37%
All Time Low Date	2025-04-07
ATR	0.07
Beta	0.25
Beta1y	0.44
Beta2y	1.73
Ch YTD	-16.92
High	2.2
High52	3.07
High52 Date	2026-01-05
High52ch	-29.53%
Low	2.16
Low52	1.65
Low52 Date	2025-09-29
Low52ch	30.91%
Ma50ch	-1.23%
Price vs 200-day SMA	-9.09%
RSI	46.23
RSI Monthly	11.29
RSI Weekly	43.41
Sharpe ratio	-0.17x
Sortino ratio	-0.13
Total Return	-16.94%
Tr YTD	-16.92
Tr1m	-4%
Tr1w	0.47%
Tr3m	-14.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$7
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.4
Earnings Revenue Estimate	12,042,136x
Earnings Revenue Estimate Growth	-34.74x
Operating Income	$-6.9M
Operating margin	-12.19
Price target	$9.5
Price Target Change	$340
Price Target Change Top	$224

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,629,855%
Float Percent	71.09%
Net Borrowing	383,000
Shares Insiders	5.63%
Shares Institutions	18.09%
Shares Out	10,733,208
Shares Qo Q	4.74%
Shares Yo Y	16.94%
Short Float	4.57%
Short Ratio	13.83
Short Shares	3.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$986,000
Average Volume	21,446.15x
Bv Per Share	3.27
CAPEX	$-34,000
Ch10y	-100
Ch1m	-4
Ch1w	0.47
Ch1y	-17.87
Ch3m	-14.29
Ch3y	19.34
Ch5y	-97.37
Ch6m	-20
Change	0%
Change From Open	-1.14
Close	2.16
Days Gap	1.16
Depreciation Amortization	4,273,000
Dollar Volume	22,472.6
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-4.1M
EBITDA	$-1.3M
EPS	$-3.71
F Score	3
FCF	$1.6M
FCF EV Yield	8.47x
FCF Per Share	$0.15
Financing CF	9,898,000
Fiscal Year End	June
Income Tax	$447,000
Investing CF	-3,034,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2023-01-06
Last Split Type	Reverse
Last10k Filing Date	2025-09-23
Ma150	2.43
Ma150ch	-11.22%
Ma20	2.18
Ma20ch	-0.96%
Net CF	8,542,000
Next Earnings Date	2026-09-22
Open	2.19
Optionable	No
P FCF Ratio	14.1
P OCF Ratio	13.82
Position In Range	0
Ppne	1,317,000
Price Date	2026-07-24
Relative Volume	0.49x
Revenue	56,599,000x
SBC By Revenue	1.16x
Share Based Comp	658,000
Tax By Revenue	0.79x
Tr6m	-20%
Us State	Colorado
Volume	10,404
Z Score	-3.82

Aytu BioPharma, Inc. (AYTU)

Coverage state: Market snapshot only — no published research

Generate the first AYTU analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · AYTU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AYTU indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AYTU

Frequently asked questions